[go: up one dir, main page]
Skip to main content
Springer Nature Link
Account

HCV and Related Liver Diseases

  • Conference proceedings
  • © 1999

Overview

Editors:
  1. Kiwamu Okita

    1. First Department of Internal Medicine, Yamaguchi University School of Medicine, Kogushi, Ube, Yamaguchi, Japan

  • Introducing the therapeutic modalities recently developed in Japan

  • 1191 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this book

Log in via an institution
Softcover Book EUR 52.74
Price includes VAT (France)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book EUR 52.74
Price includes VAT (France)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

About this book

More than 2 million people in Japan have chronic hepatitis C and many of them will lose their lives to liver cirrhosis or complications of hepatocellular carcinoma. Hepatitis C virus-related diseases are a serious concern both in developing countries and in Japan and the United States, where the number of patients is also in the millions. Therapeutic modalities recently developed in Japan, including interferon therapy and nutritional supportive therapy, are gaining worldwide acceptance. At this critical juncture, HCV and Related Liver Diseases presents new information on etiology, pathology, diagnosis, and therapy. Viral hepatitis was the theme of the Yamaguchi Symposium on Liver Disease, meeting in December 1998 and attended by leading hepatologists and virologists. Collected in this volume are the papers from the symposium, providing a valuable resource for hepatologists, gastroenterologists, and others working to understand and treat viral hepatitis.

Similar content being viewed by others

Explore related subjects

Discover the latest articles, books and news in related subjects.

Table of contents (9 papers)

  1. Front Matter

    Pages II-XII
    Download chapter PDF

  2. Hepatitis C: Current Status and Future Directions for Antiviral Therapy

    • Stanley M. Lemon
    Pages 1-26

  3. Different Quasispecies of Hepatitis C Virus in Human Serum, Peripheral Blood Mononuclear Cells, and Liver

    • Keisuke Hino, Michiari Okuda, Masaaki Korenaga, Yuhki Yamaguchi, Yoshiharu Katoh, Kiwamu Okita
    Pages 27-34

  4. High Prevalence of HCV Infection in Patients with Oral Cancer and Oral Precancerous Lesion

    • Michio Sata, Yumiko Nagao, Tadamitsu Kameyama, Kyuichi Tanikawa
    Pages 35-43

  5. Hepatitis C Virus Nonstructural Region 5A Protein: A Potent Transcriptional Activator

    • Naoya Kato, Keng-Hsin Lan, Suzane Kioko Ono-Nita, Hideo Yoshida, Yasushi Shiratori, Masao Omata
    Pages 45-58

  6. Natural Variation in Translational Activities of the 5′ Nontranslated RNAs of Genotypes 1a and 1b Hepatitis C Virus: Evidence for a Long Range RNA-RNA Interaction Outside of the Internal Ribosomal Entry Segment

    • Masao Honda, Geoff Abell, Shuichi Kaneko, Kenichi Kobayashi, Stanley M. Lemon
    Pages 59-71

  7. Mutation Pattern of Hepatitis C Virus and Its Application to Therapy

    • Masashi Mizokami, Tatsunori Nakano, Etsuro Orito
    Pages 73-84

  8. Randomized Controlled Trial of Lymphoblastoid Interferon-α for Chronic Hepatitis C; Early Disappearance of HCV RNA is Essential for Sustained Response

    • Shinichi Kakumu, IFN Treatment Group of Affiliated Hospitals of the Third Department of Internal Medicine
    Pages 85-92

  9. Use of Interferon-α for Prevention of Hepatocellular Carcinoma in Patients with Chronic Active Hepatitis C with Cirrhosis

    • S. Nishiguchi, S. Nakatani, A. Tamori, T. Takeda, S. Shiomi, S. Seki et al.
    Pages 93-102

  10. Risk Factors for Hepatocellular Carcinoma Among Chronic Hepatitis C Patients Treated with Interferon

    • Akinori Kasahara, Norio Hayashi, Shinichi Kakumu, Kendo Kiyosawa, Kiwamu Okita, The Osaka Liver Disease Study Group
    Pages 103-117

  11. Back Matter

    Pages 119-120
    Download chapter PDF
Back to top

Editors and Affiliations

  • First Department of Internal Medicine, Yamaguchi University School of Medicine, Kogushi, Ube, Yamaguchi, Japan

    Kiwamu Okita

Accessibility Information

PDF accessibility summary

This PDF is not accessible. It is based on scanned pages and does not support features such as screen reader compatibility or described non-text content (images, graphs etc). However, it likely supports searchable and selectable text based on OCR (Optical Character Recognition). Users with accessibility needs may not be able to use this content effectively. Please contact us at accessibilitysupport@springernature.com if you require assistance or an alternative format.

EPUB accessibility summary

This ePub was produced prior to the implementation of current accessibility best practices. If Math is present, it is represented either as MathML, LaTeX or in images. Text alternatives are not available for images, graphs and other non-text content. We recognize the importance of accessibility, and we welcome queries about accessibility for any of our products. If you have a question or an access need, please get in touch with us at accessibilitysupport@springernature.com.

Bibliographic Information

  • Book Title: HCV and Related Liver Diseases

  • Editors: Kiwamu Okita

  • DOI: https://doi.org/10.1007/978-4-431-68488-6

  • Publisher: Springer Tokyo

  • eBook Packages: Springer Book Archive

  • Copyright Information: Springer-Verlag Tokyo 1999

  • Hardcover ISBN: 978-4-431-70235-1Published: 01 January 1999

  • Softcover ISBN: 978-4-431-68490-9Published: 29 February 2012

  • eBook ISBN: 978-4-431-68488-6Published: 06 December 2012

  • Edition Number: 1

  • Number of Pages: XII, 120

  • Topics: Hepatology

Keywords

Publish with us

Policies and ethics

Back to top